The inadequacy of single, simple arithmetic corrections for salicylate interference in the widely employed Glynn and Kendal technique for plasma paracetamol assay is highlighted by reference to an actual case of combined salicylate/paracetamol intoxication in an infant. Attention is drawn for the first time to the not insubstantial contribution to such interference made by even the minor metabolites of salicylate. The conclusion is reached that it is necessary, particularly in the assessment of paracetamol toxicity, to determine the presence of salicylate, and when present, to employ a specific method for the estimation of paracetamol.
Salicylate is known to contribute a positive bias when paracetamol estimations are made by the spectrophotometric assay recommended by the American Academy of Pediatrics. I. 2 Several methods have been used to remove this bias such as solvent extraction;' or, commonly, by allowing for it by arithmetic correction.v? Recent publications'"!" echo the recommendations of Rosenbaum et al.s. h that each laboratory should determine its own correction factor, appropriate to its own conditions and assay protocol.
We here report a study of a non-fatal combined salicylate and paracetamol intoxication in an infant which indicates the serious and clinically misleading inadequacies of the various recommended correction factors.
Brief case report A 6-week-old infant presented to the casualty department, in a moribund and dehydrated state requiring emergency resuscitation. The initial measurement of arterial blood gases revealed a compensated metabolic acidosis and an increased plasma anion gap (pH 7·34, PC02 23 mmHg, HC0 3 -12·5 mrnol/L, Na+ 145 mrnol/L, Cl" 106 mrnol/L). At this stage the possibility of drugs being given by the parents Correspondence: Neil R Badcock was raised: the parents denied any knowledge of drug administration.
On the third day a toxicology screen was carried out on the blood and urine samples which had been collected shortly after the patient's admission. These samples showed the presence of paracetamol and salicylate; further screening tests excluded other drugs. As the initial plasma sample appeared to show very high concentrations of paracetamol and aspirin metabolites, further drug measurements were carried out on plasma samples which had previously been collected at intervals following admission for acid-base and electrolyte determinations (Table 1) .
After the initial rehydration and standard intensive-care management of his cardiorespiratory state, the patient's clinical condition improved. Managed conservatively thereafter, he gradually made an uneventful recovery and was discharged 1 week later. When reviewed 3 months after discharge, he was healthy with no handicap evident on clinical examination.
The parents, confronted with the toxicology data, finally admitted to adding Panadol'P and Aspro Clear lBl to each feed for the 2 days prior to admission to control symptoms of fever and irritability.
Materials and methods
All plasma samples were stored frozen at -20°C until analysis. Analytical grade reagents were used. Gentisuric acid was synthesized from gentisic acid and glycine ethylester.!' Salicylic acid (SA), salicyluric acid (SU), gentisic acid (GA) and gentisuric acid (GU) were determined in plasma by a specific HPLC method'f using the alternative isocratic solvent elution system.
Paracetamol in plasma was determined by both the recommended? colorimetric nitration procedure of Glynn and Kendall and by an interference-free HPLC method. Glass test tubes (100 x 13 mm) fitted with Teflon-lined screw caps were used for the final nitration reaction mixture? and sample and reagent volumes were reduced to one-quarter of those originally specified by Glynn and Kendal. I Samples were prepared for the HPLC method by mixing 100 ul, of plasma and 100 ul, of acetonitrile containing 47 umol/L of 8chlorotheophylline as internal standard; a 10 ilL aliquot of the supernatant was chromatographed on a Radial-Pak C18 cartridge (100 x 8 mm, 5 urn average particle size, Waters Associates Inc, Mass.). The solvent used for the chromatography was acetonitrile and 5 mmol/L aqueous acetate buffer pH 4·0 (11:89, v/v) which was pumped at a flow rate of2·5 mUmin. The retention time for paracetamol was 4·5 min and for the internal standard 8·8 min. Paracetamol and the internal standard were detected by their absorption at 280 nm.
Five standard solutions of paracetamol (50, 100, 250, 500 and 1000 umol/L) were used to determine the ratios of the peak heights of paracetamol to the peak heights of 8chlorotheophylline. The peak-height ratios were linearly related to the concentration of paracetamol so that concentration in unknown samples were calculated by direct proportion. Aspirin and its metabolites did not interfere in the assay of paracetamol by HPLC.
Results and discussion
The patient's paracetamol and aspirin metabolite concentrations during course of hospitalization are shown in Table 1 . In this infant all aspirin metabolites were present in concentrations many times those of the peak concentrations expected following therapeutic ingestion of aspirin.P'!" GA and GU co-eluted in the solvent elution system used-their similar molar absorptivities at 280 nm in the HPLC solvent elution system used l2 made it possible to report the concentration of these two aspirin metabolites as a 'combined' concentration.
The paracetamol concentrations and the apparent half-life of elimination (t. . . . J, determined using the Glynn and Kendal method l were compared with those obtained from the specific HPLC procedure ( Table 1) . t. . . . , values for paracetamol determined by the colorimetric procedures are about threefold greater than those determined by the HPLC method and more closely reflect the rate of elimination of salicylate and its metabolites. Whatever the corrections for SA, the results from the colorimetric Glynn and Kendal procedure are significantly higher than HPLC assay results and could be taken to indicate possible hepatocellular injury and thus the need for treatment with antidote." These divergent sets of results contradict a statement from Mace and Walker,4 who, following experiments where sodium salicylate was added to plasma concluded that 'the effect of salicylate on the method of Glynn and Kendal is not so great as to be likely to affect clinical decisions'. This is clearly not so: the results on this patient could well have led to the unnecessary administration of N-acetylcysteine and exposing the patient to the risk of an anaphylactoid reaction.P"!"
Reed et al. s recently reinforced the observation that interference from salicylate should be based on SA, not acetylsalicylic acid. SA presumably undergoes a similar nitration reaction to paracetarnol in the Glynn and Kendal procedure 1 and the resulting nitrophenols are coloured yellow in alkaline solution; the three equations'"? used nominally to correct for 6·0 5·0 3·0 4·0
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Salicylate interference in plasma paracetamol assay 529 interference were based on behaviour of the pure drug SA added to the assay system. To examine whether other aspirin metabolites also undergo ring nitration and form a yellow complex, and if so, to define their contribution relative to SA in the colorimetric reaction, we added equimolar concentrations of SA, SU, GA and GU to drug-free pooled human plasma and assayed for apparent plasma paracetamol by the method of Glynn and Kendal. l The results obtained are illustrated in Fig. 1 . GU, SU and GA are shown to be approxi-~~~;
:::~~==~==:===:~==:mately five, eight and thirteen times respectively more effective in molar terms than SA in producing spurious paracetamol concentrations. Thus the inability of anI of the three standard correction equations 7 to account adequately for the contribution by salicylate in this actual case of combined salicylate/ paracetamol intoxication in which renal failure had led to significant impairment in the excretion of all of the aspirin metabolites is almost certainly due to the incorporation of only one metabolite, SA, into the correction factor, and failing to take account also to SU, GU and GA. Despite the plasma concentration of these minor metabolites being many times less than that of SA, their increased molar chromogenicity makes a very significant contribution towards the level of interference.
Although two previous reportsl?' 20 claim only small reduction in interference associated with measuring the absorbance of the final reaction mixture in the Glynn and Kendal method at 450 nm rather than 430 nm, other authors" 9 support our findings of an approximate 60% reduction in interference effect of SA with negligible effect on sensitivity of paracetamol determinations (Fig. 2) . Increasing the wavelength from 430 nm to 450 nm also decreases the interference due to salicyluric acid (the major metabolite of SA) by 65% but has only a marginal effect on the interference by GA (10% decrease) and GU (20% decrease).
The correction of plasma concentrations of paracetamol for interference by SA alone is inadequate because interference by metabolites is not taken into account; more precise correction would require the assay of individual metabolites of SA which would be timeconsuming. Consequently, where the possibility of overdose of paracetamol and salicylate coexist, a method for the specific determination of paracetamol, e.g. by HPLC,21-23 or an EMI'Pli procedure/" would seem mandatory. 
